Creating physiologically relevant conditions for cells that replicate in vivo environments can improve experimental results, ...

Tanning beds not only increase melanoma risk but also inflict a molecular toll, causing a spike in DNA mutations within skin ...

Yamagami, and Amaris Castañon will discuss the latest advances and innovations in neuroscience disease cell models.

A strange, contagious cancer is threatening Tasmanian devils, but researchers’ fight is fueling breakthroughs in science, ...

Early-life viral infection programs immune cells to hijack allergy-associated maternal antibodies, driving allergy risk later ...

The end of the shutdown did not resolve the uncertainty facing US researchers, who continue to navigate delays and budget ...

Jesse Dixon, MD, PhD, is an associate professor and a member of the NCI-Designated Cancer Center at the Salk Institute for ...

Dmitry Lyumkis, PhD, is an associate professor and Hearst Foundations Developmental Chair at the Salk Institute for ...

From rare diseases to chronic conditions, epigenetic editing unlocks new ways to control gene activity without altering the genetic code.

Derek Jantz is the Chief Scientific Officer at Tune Therapeutics. A veteran entrepreneur with deep expertise in developing cell and gene therapeutics, Dr. Jantz was previously CSO at Precision ...

Erythropoietin, the protein that drives red blood cell formation, also induces tolerance in dendritic cells, leading to the ...

Sequencing diverse populations revealed over 41,000 transcripts missing in Eurocentric references, exposing ancestry bias ...